David Erlinge
11 – 20 of 498
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
(
- Contribution to journal › Article
-
Mark
Increased fluid accumulation, reduced physical activity and heart rate variability during national holidays in patients with cardiac implantable electronic devices.
(
- Contribution to journal › Article
-
Mark
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similarities
2025) In Cardiovascular Research(
- Contribution to journal › Article
-
Mark
Non-invasive pressure-volume loops provide incremental value to age, sex, and infarct size for predicting adverse cardiac remodelling after ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction : A Prospect II Substudy
(
- Contribution to journal › Article
- 2024
-
Mark
Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events
(
- Contribution to journal › Article
-
Mark
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction : a nationwide observation registry study from SWEDEHEART
(
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
(
- Contribution to journal › Article
-
Mark
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
(
- Contribution to journal › Article